Published in J Mol Biol on September 29, 2000
Biodegradation of aromatic compounds by Escherichia coli. Microbiol Mol Biol Rev (2001) 2.50
Quorum-quenching microbial infections: mechanisms and implications. Philos Trans R Soc Lond B Biol Sci (2007) 1.85
Genomic analysis reveals versatile organisms for quorum quenching enzymes: acyl-homoserine lactone-acylase and -lactonase. Open Microbiol J (2011) 1.49
Unconventional serine proteases: variations on the catalytic Ser/His/Asp triad configuration. Protein Sci (2008) 1.44
Identification of extracellular N-acylhomoserine lactone acylase from a Streptomyces sp. and its application to quorum quenching. Appl Environ Microbiol (2005) 1.38
Identification of QuiP, the product of gene PA1032, as the second acyl-homoserine lactone acylase of Pseudomonas aeruginosa PAO1. Appl Environ Microbiol (2006) 1.13
The quorum-quenching N-acyl homoserine lactone acylase PvdQ is an Ntn-hydrolase with an unusual substrate-binding pocket. Proc Natl Acad Sci U S A (2009) 1.02
Insights into cis-autoproteolysis reveal a reactive state formed through conformational rearrangement. Proc Natl Acad Sci U S A (2012) 0.99
The PaaX repressor, a link between penicillin G acylase and the phenylacetyl-coenzyme A catabolon of Escherichia coli W. J Bacteriol (2004) 0.95
New active site oriented glyoxyl-agarose derivatives of Escherichia coli penicillin G acylase. BMC Biotechnol (2007) 0.90
Improvement of posttranslational bottlenecks in the production of penicillin amidase in recombinant Escherichia coli strains. Appl Environ Microbiol (2003) 0.89
Structural constraints on autoprocessing of the human nucleoporin Nup98. Protein Sci (2008) 0.89
Role of alphaArg145 and betaArg263 in the active site of penicillin acylase of Escherichia coli. Biochem J (2002) 0.88
Production of a fully functional, permuted single-chain penicillin G acylase. Protein Sci (2004) 0.88
Cloning, overexpression, and characterization of a novel thermostable penicillin G acylase from Achromobacter xylosoxidans: probing the molecular basis for its high thermostability. Appl Environ Microbiol (2004) 0.87
Cloning, preparation and preliminary crystallographic studies of penicillin V acylase autoproteolytic processing mutants. Acta Crystallogr Sect F Struct Biol Cryst Commun (2004) 0.86
Autoproteolytic activation of human aspartylglucosaminidase. Biochem J (2004) 0.85
Mutations of penicillin acylase residue B71 extend substrate specificity by decreasing steric constraints for substrate binding. Biochem J (2003) 0.84
Protein engineering of penicillin acylase. Acta Naturae (2010) 0.84
Insight into autoproteolytic activation from the structure of cephalosporin acylase: a protein with two proteolytic chemistries. Proc Natl Acad Sci U S A (2006) 0.82
Mutation of Residue βF71 of Escherichia coli Penicillin Acylase Results in Enhanced Enantioselectivity and Improved Catalytic Properties. Acta Naturae (2009) 0.78
Improvement of catalytic properties of Escherichia coli penicillin G acylase immobilized on glyoxyl agarose by addition of a six-amino-acid tag. Appl Environ Microbiol (2005) 0.77
Cloning, overexpression, crystallization and preliminary X-ray crystallographic analysis of a slow-processing mutant of penicillin G acylase from Kluyvera citrophila. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.77
Heterologous expression of leader-less pga gene in Pichia pastoris: intracellular production of prokaryotic enzyme. BMC Biotechnol (2010) 0.77
Functional expression of a penicillin acylase from the extreme thermophile Thermus thermophilus HB27 in Escherichia coli. Microb Cell Fact (2012) 0.76
The N-terminal nucleophile serine of cephalosporin acylase executes the second autoproteolytic cleavage and acylpeptide hydrolysis. J Biol Chem (2011) 0.76
Structure mediation in substrate binding and post-translational processing of penicillin acylases: Information from mutant structures of Kluyvera citrophila penicillin G acylase. Protein Sci (2015) 0.75
High-throughput strategies for penicillin G acylase production in rE. coli fed-batch cultivations. BMC Biotechnol (2014) 0.75
In-silico structural and functional characterization of a V. cholerae O395 hypothetical protein containing a PDZ1 and an uncommon protease domain. PLoS One (2013) 0.75
Overexpression of penicillin V acylase from Streptomyces lavendulae and elucidation of its catalytic residues. Appl Environ Microbiol (2015) 0.75
Deciphering Physiological Functions of AHL Quorum Quenching Acylases. Front Microbiol (2017) 0.75
Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr D Biol Crystallogr (2001) 21.01
Efficient anisotropic refinement of macromolecular structures using FFT. Acta Crystallogr D Biol Crystallogr (1999) 15.91
Automated refinement of protein models. Acta Crystallogr D Biol Crystallogr (1993) 7.88
Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med (1997) 7.61
Incorporation of prior phase information strengthens maximum-likelihood structure refinement. Acta Crystallogr D Biol Crystallogr (1998) 6.47
Effect of out-of-hospital pediatric endotracheal intubation on survival and neurological outcome: a controlled clinical trial. JAMA (2000) 6.41
Presenting your structures: the CCP4mg molecular-graphics software. Acta Crystallogr D Biol Crystallogr (2011) 6.27
ARP/wARP and molecular replacement. Acta Crystallogr D Biol Crystallogr (2001) 6.03
wARP: improvement and extension of crystallographic phases by weighted averaging of multiple-refined dummy atomic models. Acta Crystallogr D Biol Crystallogr (1997) 5.58
Complex between the subtilisin from a mesophilic bacterium and the leech inhibitor eglin-C. Acta Crystallogr B (1991) 4.29
Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet (1999) 4.22
The crystal structure of EcoRV endonuclease and of its complexes with cognate and non-cognate DNA fragments. EMBO J (1993) 4.11
The kinetics of phytochrome conversion. J Biol Chem (1966) 4.05
Nomenclature for sugar-binding subsites in glycosyl hydrolases. Biochem J (1997) 3.82
Structural basis for control by phosphorylation. Chem Rev (2001) 3.53
Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. Clin Infect Dis (1996) 3.52
The stereochemical mechanism of the cooperative effects in hemoglobin revisited. Annu Rev Biophys Biomol Struct (1998) 3.47
Adjuvant systemic therapy and survival after breast cancer. N Engl J Med (1994) 3.35
The structure of 2Zn pig insulin crystals at 1.5 A resolution. Philos Trans R Soc Lond B Biol Sci (1988) 3.30
A model for interfacial activation in lipases from the structure of a fungal lipase-inhibitor complex. Nature (1991) 3.29
Informed consent in emergency research. Consensus statement from the Coalition Conference of Acute Resuscitation and Critical Care Researchers. JAMA (1995) 3.25
The crystal structure of the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia at 1.7 A resolution. J Mol Biol (1998) 3.24
Evidence for control of synthesis of the varible regions of the heavy chains of immunoglobulins G and M by the same gene. Proc Natl Acad Sci U S A (1970) 2.96
A modified ACORN to solve protein structures at resolutions of 1.7 A or better. Acta Crystallogr D Biol Crystallogr (2005) 2.95
3-A resolution structure of a protein with histone-like properties in prokaryotes. Nature (1984) 2.92
Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature (1995) 2.68
Crystal structure of a bacterial chitinase at 2.3 A resolution. Structure (1994) 2.56
The structure of trp RNA-binding attenuation protein. Nature (1995) 2.55
Automated refinement for protein crystallography. Methods Enzymol (1997) 2.35
Atomic positions in rhombohedral 2-zinc insulin crystals. Nature (1971) 2.31
Prospective evaluation of emergency department medical clearance. Ann Emerg Med (1994) 2.30
Low-temperature studies on phytochrome: light and dark reactions in the red to far-red transformation and new intermediate forms of phytochrome. Proc Natl Acad Sci U S A (1968) 2.05
The structural basis of sequence-independent peptide binding by OppA protein. Science (1994) 2.05
Is admission medically justified for all patients with acute stroke or transient ischemic attack? Ann Emerg Med (1995) 2.05
New-onset atrial fibrillation: when is admission medically justified? Acad Emerg Med (1996) 2.04
Bacterial chitobiase structure provides insight into catalytic mechanism and the basis of Tay-Sachs disease. Nat Struct Biol (1996) 1.98
KINETICS OF PHYTOCHROME CONVERSION: MULTIPLE PATHWAYS IN THE P(r) TO P(fr) REACTION, AS STUDIED BY DOUBLE-FLASH TECHNIQUE. Proc Natl Acad Sci U S A (1967) 1.96
Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J (2000) 1.94
Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone. J Clin Invest (1974) 1.85
Gallstone pancreatitis: a prospective study on the incidence of cholangitis and clinical predictors of retained common bile duct stones. Am J Gastroenterol (1998) 1.77
Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study. Circulation (1996) 1.76
High resolution structures of holo and apo formate dehydrogenase. J Mol Biol (1994) 1.75
Implementing the Food and Drug Administration's final rule for waiver of informed consent in certain emergency research circumstances. Acad Emerg Med (1999) 1.71
Crystal structure of the type-2 Cu depleted laccase from Coprinus cinereus at 2.2 A resolution. Nat Struct Biol (1998) 1.70
Phenol stabilizes more helix in a new symmetrical zinc insulin hexamer. Nature (1989) 1.69
Clinical validation of a structural porous tantalum biomaterial for adult reconstruction. J Bone Joint Surg Am (2004) 1.68
Ciguatera: recent advances but the risk remains. Int J Food Microbiol (2000) 1.67
Immediate countershock versus cardiopulmonary resuscitation before countershock in a 5-minute swine model of ventricular fibrillation arrest. Ann Emerg Med (2000) 1.66
A new proposal for urease mechanism based on the crystal structures of the native and inhibited enzyme from Bacillus pasteurii: why urea hydrolysis costs two nickels. Structure (1999) 1.66
Conformational stability and thermodynamics of folding of ribonucleases Sa, Sa2 and Sa3. J Mol Biol (1998) 1.64
Determining the need for admission in patients with new-onset seizures. Ann Emerg Med (1994) 1.64
Crystal structure of GerE, the ultimate transcriptional regulator of spore formation in Bacillus subtilis. J Mol Biol (2001) 1.62
Evaluation and management of children younger than two years old with apparently minor head trauma: proposed guidelines. Pediatrics (2001) 1.61
Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man. Clin Pharmacol Ther (1974) 1.61
A common protein fold and similar active site in two distinct families of beta-glycanases. Nat Struct Biol (1995) 1.60
Outcome of out-of-hospital postcountershock asystole and pulseless electrical activity versus primary asystole and pulseless electrical activity. Crit Care Med (2001) 1.59
A protein structural motif that bends DNA. Proteins (1989) 1.57
Ciguatera and mannitol: experience with a new treatment regimen. Med J Aust (1989) 1.55
Maffucci's syndrome: functional and neoplastic significance. Case report and review of the literature. J Bone Joint Surg Am (1973) 1.54
Enzymatic ketonization of 2-hydroxymuconate: specificity and mechanism investigated by the crystal structures of two isomerases. Biochemistry (1996) 1.52
Molecular structure of a new family of ribonucleases. Nature (1982) 1.52
The structure of the cofactor-binding fragment of the LysR family member, CysB: a familiar fold with a surprising subunit arrangement. Structure (1997) 1.50
Men, muscles, and body image: comparisons of competitive bodybuilders, weight trainers, and athletically active controls. Br J Sports Med (2005) 1.48
Transmission of conformational change in insulin. Nature (1983) 1.48
Ashman's phenomenon--a source of nonsustained wide-complex tachycardia: case report and discussion. J Emerg Med (1992) 1.46
The assay of warfarin in plasma or stool. Biochem Med (1970) 1.45
Structure of the pig insulin dimer in the cubic crystal. Acta Crystallogr B (1991) 1.45
Crystal structure of the p-hydroxybenzoate hydroxylase-substrate complex refined at 1.9 A resolution. Analysis of the enzyme-substrate and enzyme-product complexes. J Mol Biol (1989) 1.44
Crystal structure of PvuII endonuclease reveals extensive structural homologies to EcoRV. Nat Struct Biol (1994) 1.43
Zinc- and iron-rubredoxins from Clostridium pasteurianum at atomic resolution: a high-precision model of a ZnS4 coordination unit in a protein. Proc Natl Acad Sci U S A (1996) 1.43
11-fold symmetry of the trp RNA-binding attenuation protein (TRAP) from Bacillus subtilis determined by X-ray analysis. J Mol Biol (1994) 1.42
Statistical models and Occam's razor. Acad Emerg Med (1999) 1.42
The application of direct methods and Patterson interpretation to high-resolution native protein data. Acta Crystallogr D Biol Crystallogr (1993) 1.42
Structural stability in the 4-zinc human insulin hexamer. Proc Natl Acad Sci U S A (1984) 1.42
Binding of buried structural water increases the flexibility of proteins. Proc Natl Acad Sci U S A (1999) 1.41
The benefits of atomic resolution. Curr Opin Struct Biol (1997) 1.41
The crystal and molecular structure of the Rhizomucor miehei triacylglyceride lipase at 1.9 A resolution. J Mol Biol (1992) 1.41
Crystal structure of a dUTPase. Nature (1992) 1.41
Ribonuclease from Streptomyces aureofaciens at atomic resolution. Acta Crystallogr D Biol Crystallogr (1996) 1.40
The crystal structure of the globular domain of sheep prion protein. J Mol Biol (2004) 1.36
X-ray analysis of the single chain B29-A1 peptide-linked insulin molecule. A completely inactive analogue. J Mol Biol (1991) 1.36
The X-ray structure of a cobalamin biosynthetic enzyme, cobalt-precorrin-4 methyltransferase. Nat Struct Biol (1998) 1.35
Penicillin V acylase crystal structure reveals new Ntn-hydrolase family members. Nat Struct Biol (1999) 1.35
Warfarin resistance. Am J Med (1967) 1.35
Molecular dynamics refinement of a thermitase-eglin-c complex at 1.98 A resolution and comparison of two crystal forms that differ in calcium content. J Mol Biol (1989) 1.34
The three-dimensional structure of a Trichoderma reesei beta-mannanase from glycoside hydrolase family 5. Acta Crystallogr D Biol Crystallogr (2000) 1.34
Zinc-free cubic pig insulin: crystallization and structure determination. J Mol Biol (1978) 1.34
Regulatory features of the trp operon and the crystal structure of the trp RNA-binding attenuation protein from Bacillus stearothermophilus. J Mol Biol (1999) 1.32
Structure and function of endoglucanase V. Nature (1993) 1.31
Structure of the intact transactivation domain of the human papillomavirus E2 protein. Nature (2000) 1.30
Calcium binding in alpha-amylases: an X-ray diffraction study at 2.1-A resolution of two enzymes from Aspergillus. Biochemistry (1990) 1.29
Warfarin metabolites: the anticoagulant activity and pharmacology of warfarin alcohols. J Lab Clin Med (1973) 1.27
muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. Proc Natl Acad Sci U S A (2006) 1.26